| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439650 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
Chemoradiotherapy with ENI and erlotinib might represent a substantial improvement on the standard of care for inoperable ESCC. ENI alone should be adopted in concurrent chemoradiotherapy for ESCC patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shi-Xiu Wu, LV-Hua Wang, Hong-Lei Luo, Cong-Ying Xie, Xue-Bang Zhang, Wei Hu, An-Ping Zheng, Duo-Jie Li, Hong-Yan Zhang, Cong-Hua Xie, Xi-Long Lian, De-Xi Du, Ming Chen, Xiu-Hua Bian, Bang-Xian Tan, Hao Jiang, Hong-Bo Zhang, Jian-Hua Wang, Gang Li,